Serum Levels of Interleukin-18 and sICAM-1 in Patients Affected by Breast Cancer: Preliminary Considerations
Authors:
Open Access
- 1 January 2001
- journal article
- research article
- Published by SAGE Publications in The International Journal of Biological Markers
- Vol. 16 (2) , 126-129
Abstract
Interleukin-18 (IL-18), a cytokine that plays an important role in the T-cell-helper type 1 response, acts as an angiogenesis and tumor suppressor. Intercellular adhesion molecule-1 (ICAM-1) has a potential role in immunoregulation by mediating immune cell infiltration into the tissue. The aim of this study was to evaluate IL-18 and soluble (s) ICAM-1 serum levels in breast cancer (BCa) patients with liver (BCaM1h) or bone (BCaM1b) metastases compared to BCa patients without metastases (BCaM0) and healthy donors (HDs). Furthermore, since IL-18 enhances ICAM-1 expression, we investigated whether there was a direct correlation between sICAM-1 and IL-18 serum levels. Serum IL-18 and sICAM-1 levels were assayed by immunoenzymatic methods. The serum sICAM-1 levels in the three groups of cancer patients were significantly higher (ps. Serum IL-18 levels were significantly higher (p<0.05) in BCaM1h and BCaM1b patients compared to BCaM0 patients and HDs. sICAM-1 proved to be closely correlated with serum IL-18 levels in HDs, whereas a weaker correlation was found in BCaM1h, BCaM1b and BCaM0 patients. The defective correlation between sICAM-1 and IL-18 found in cancer patients may contribute to our understanding of the immunity upset occurring in cancer. Our data suggest that IL-18, irrespective of its biological activity, could represent a marker for metastatic breast cancer.Keywords
This publication has 15 references indexed in Scilit:
- Elevation of serum interleukin-18 levels and activation of kupffer cells in biliary atresiaJournal of Pediatric Surgery, 2000
- In Vitro Interleukin-8 Production by Monocytes Treated with Lithium Chloride from Breast Cancer PatientsTumori Journal, 2000
- In VitroEffect of Lithium Chloride on Interleukin-15 Production by Monocytes from Breast Cancer PatientsJournal of Chemotherapy, 2000
- Interleukin‐18 acts as an angiogenesis and tumor suppressorThe FASEB Journal, 1999
- IL-18: A TH1 -inducing, proinflammatory cytokine and new member of the IL-1 familyJournal of Allergy and Clinical Immunology, 1999
- Interleukin-18/interferon-γ-inducing factor, a novel cytokine, up-regulates ICAM-1 (CD54) expression in KG-1 cellsJournal of Leukocyte Biology, 1998
- Interleukin-18 (Interferon-γ–inducing Factor) Is Produced by Osteoblasts and Acts Via Granulocyte/Macrophage Colony-stimulating Factor and Not Via Interferon-γ to Inhibit Osteoclast FormationJournal of Experimental Medicine, 1997
- In vivo antitumor effects of murine interferon- γ -inducing factor/interleukin-18 in mice bearing syngeneic Meth A sarcoma malignant ascitesCancer Immunology, Immunotherapy, 1997
- The Significance of Soluble lnterleukin-2, Soluble Interleuk in-2 Receptors, Soluble ICAM-1 and β2-Microglobulin in Breast Cancer PatientsTumor Biology, 1995
- Peripheral blood natural killer cell activity in human breast cancer patients and its modulation by T-cell growth factor and autologous plasmaCancer, 1986